- [PRESSWIRE] Germany – 21 December, 2020 — N-PATH is the most innovative European training course in interventional nephrology funded by European Commission in the framework of the Erasmus+ program coordinated by the University of Bari, in collaboration with the European Renal Association (ERA-EDTA), the Vascular Access Society, important international academic centers and two companies specialized in medical training.
- [PRESSWIRE] Denmark – 14 December, 2020 — Many challenges are associated with the conventional eye drop bottle. The global ophthalmic industry has long pushed for a way to better deliver medication to the eye. Now, the Danish-based MedTech start-up, EYE-GO, has the solution that can improve the lives of millions of people globally suffering from dry eyes and other chronic eye conditions. Leading ophthalmologists and frontrunning international players in the industry have already named it “a true game-changer in eye care”. The Danish state participated in the latest funding round.
- [PRESSWIRE] UK – 18.11.20 — Hundreds of religious leaders from around the world gather to pray for the end of COVID-19 ahead of a group plasma donation by 4,000 Shincheonji members…
- [PRESSWIRE] CA, US – 18 September, 2020 — Airionex announced today the results of new independent testing. Varionix® active bipolar ionization air cleaning technology from Airionex has been verified to be effective for disinfecting coronavirus from the air. The virus was completely eliminated within minutes.
- [PRESSWIRE] Parma, Italy – August 31, 2020 — Two randomized controlled studies show: SGLT2 inhibitors can slow chronic kidney disease (CKD) progression in all patients, not only in diabetics. Results of one study [1] were presented at the virtual ESC Congress 2020 and the results of the other were published in NEJM [2].
- [PRESSWIRE] Israel – 13 August, 2020 — Kanabo Research LTD und Simply Green BV haben eine exklusive Vertriebsvereinbarung unterzeichnet, um die medizinische Verdampfungstechnologie von Kanabo auf den deutschen Markt zu bringen. Im Rahmen der Vereinbarung erhält Simply Green das exklusive Vertriebsrecht für die proprietäre Lieferplattform Kanabo VapePod® und Rezepturen über dessen Vertriebsnetz.
- [PRESSWIRE] SECAUCUS, N.J., April 21, 2020 — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood samples. With the new service, Quest Diagnostics now provides healthcare providers in the United States access to COVID-19 antibody as well as molecular diagnostic laboratory testing.
- [PRESSWIRE] ALBANY, New York, June 9, 2020 — Video telemedicine has become an integral part of remote health care services, gaining popularity due to their use in chronic disease management, driving the evolution of the video telemedicine market. In the light of emerging coronavirus disease (COVID-19) pandemic and subsequent social distancing restrictions, video telemedicine services have become a necessity for a substantial portion of patient populations, especially in disease diagnosis.
- [PRESSWIRE] Vienna – 4 June, 2020 — The Austrian biotech company CEBINA GmbH announces that it has received seed funding for its extended spectrum Coronavirus vaccine project, which is part of CEBINA’s broad-scale efforts offering short-, mid- and longer-term solutions to fight the COVID-19 pandemic. This seed funding will support proof-of-concept studies of the vaccine that will allow progress to pre-clinical development, scheduled for Q1/2021. The funds are provided by the Blom Family Office.
- [PRESSWIRE] Luxembourg – 14 May, 2020 — The pandemic has taken the medical world by surprise and challenged the medical device industry, putting a heavy strain on manufacturers. How does a CEO juggle between the intensifying demand for reliable medical equipment, the need for innovations, and the safety of his employees to make sure that COVID-19 is behind us in the shortest time possible?
- [PRESSWIRE] Austria – 20 April, 2020 — Austrian biotech company Calyxha Biotechnologies GmbH is pleased to announce the grant of European Patent No. EP3383381. This patent covers the use of calixarene compounds for neurodegenerative diseases, including Parkinson’s disease. It represents the company’s first granted patent, with prosecution of the corresponding patent applications ongoing in other territories.
- [PRESSWIRE] Parma, Italy – April 9, 2020 — The ERA-EDTA has established a European database that collects granular data of individual dialysis patients and transplanted patients with COVID-19. The hope is to achieve insights into patient and treatment characteristics that are related to outcome and to learn about modifiable risk factors, which would help to improve prognoses.
- [PRESSWIRE] Reykjavik, Iceland – 26 March 2020 — The first Coronavirus Medical Express flight departs Shanghai at 23:30 GMT today airlifting urgently needed supplies to fight the coronavirus from China to Europe.
- [PRESSWIRE] 19.03.20 – Chicago, IL. – Surgisphere ha sviluppato uno strumento per il triage del COVID-19 che aiuta a gestire le priorità nelle cure per i pazienti in urgente stato di necessità.
- [PRESSWIRE] Chicago, IL United States – 19 March, 2020 — Surgisphere has developed a COVID-19 triage tool that helps prioritize care for patients who are in urgent need of care.
- [PRESSWIRE] Parma, Italy – March 12, 2020 — Kidney involvement seems to be frequent in patients who have tested positive for coronavirus. Acute kidney injury might be a predictor of mortality in infected patients.
- [PRESSWIRE] Parma, Italy – 11 March, 2020 – Dialysis centers should not be tipped into panic but need to adopt common sense precautions. ERA-EDTA has therefore published a set of guidelines recommending several well-balanced measures to dialysis centers.
- [PRESSWIRE] Parma, February 26, 2020 – Study shows that patients older than 75 years who received a kidney from a similarly aged donor remain dialysis-free for the rest of their lives!
- [PRESSWIRE] 29 January, 2020 – UK — New research released today reveals that the average football fan in the United States, will eat a staggering 10,821 calories and 180 grams of saturated fat this Super Bowl Sunday.
- [PRESSWIRE] Atlanta, Ga. – 14 gennaio 2020 — Il Team Novo Nordisk, la prima squadra ciclistica professionistica al mondo interamente composta da corridori con diabete, correrà la stagione 2020 su telai Colnago completi di componenti, freni a disco e misuratori di potenza Shimano di2, indossando kit progettati dalla GSG.
- [PRESSWIRE] Atlanta, Ga. – 14 January, 2020 —Team Novo Nordisk, the world’s first all-diabetes pro cycling team, will race the 2020 season on Colnago frames complete with Shimano di2 components, disc brakes, and power meters while wearing GSG-designed kits.
- [PRESSWIRE] UK – 10 January, 2020 — To coincide with Blue Monday on January 20th, electronics retailer Ebuyer has conducted a survey into the link between mental health and online help.
- [PRESSWIRE] Parma – December 19, 2019 — The 2017 Annual Report of the ERA-EDTA Registry [1] reveals that only a small fraction of patients accepted for renal replacement therapy are able to start this treatment with the best available therapy, which is transplantation, – and that the number of people who are in need of renal replacement therapy is rising. This poses a major challenge to our health systems, therefore everything should be done to fight this trend, e.g. by strengthening prevention.
- [PRESSWIRE] Parma, November – 18, 2019 — High protein intake is believed to be healthy, but it may pave the way to irreversible kidney failure. The risk of the kidneys being harmed by a diet rich in proteins is especially high in people with a pre-existing low-grade chronic kidney disease, of which most of the affected people are unaware. “It is essential that people know there is another side to high-protein diets.”
- [PRESSWIRE] BOSTON, Nov. 18, 2019 — Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, announced today it has been selected by Novartis, a global healthcare company, to collaborate on a commercial project for managing patients with heart failure (HF) beginning in Southeast Asia, with potential plans to expand globally. The goal of the program is to improve clinical outcomes by using Biofourmis’ lead product BiovitalsHF™, which captures data from wearable biosensors and leverages the FDA-cleared Biovitals™ Analytics Engine to identify early signs of HF exacerbations to enable early interventions in patients with HF with reduced ejection fraction.
- [PRESSWIRE] Parma – November 12, 2019 – Diabetes is one of the key drivers of chronic kidney disease and the most frequent reason why patients are in need of renal replacement therapy. Conversely, outcomes for dialysis patients with diabetes are rather poor. For these reasons, the ERA-EDTA aims to raise awareness of the threat of kidney disease on World Diabetes Day on November 14. It is important to prevent diabetes wherever possible and if not, to take great care to ensure that kidney health is protected in diabetic patients. SGLT2 inhibitors have the potential to treat CKD in patients with diabetes.
- [PRESSWIRE] DENVER, Oct. 24, 2019 — Aspen Laser Systems, LLC, an emerging leader in laser therapy, also referred to as Photobiomodulation, announced that it has been recognized with an award by Global Health & Pharma, a leading publication and information sharing platform, dedicated to the healthcare industry.
- [PRESSWIRE] ITALY – 15 October, 2019 — The 18th Congress of the International Pediatric Nephrology Association (IPNA) will take place in Venice, Italy, from 17-21 October 2019. IPNA’s vision is to achieve optimal care for all children with kidney disease all over the world through advocacy, education, and training in developed countries as well as in under-resourced regions. By means of the Congress and various educational programs, IPNA disseminates knowledge in order to improve the situation of more than 23,000 children on chronic renal replacement therapy.
- [PRESSWIRE] LONDON, July 29, 2019 — In 2018, the urology devices market is estimated at $6.9bn and is expected to grow at a CAGR of 6.1% from 2018 to 2029. The urinary incontinence market dominated the market in 2018 and accounted for 33.8% of the urology devices market.
- [PRESSWIRE] London – 09 July 2019 — The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients. Over 850 million people suffer from kidney diseases worldwide, a number which signifies epidemic proportions, yet these patients are still ignored by investigators and initiators of clinical trials in all medical fields – and are thus excluded from clinical trials. ASN, ERA-EDTA and ISN, collaboratively aim to bring about a paradigm change in medical research and have launched an information campaign to that end.